相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anaplastic lymphoma kinase: signalling in development and disease
Ruth H. Palmer et al.
BIOCHEMICAL JOURNAL (2009)
Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
Lorena Passoni et al.
CANCER RESEARCH (2009)
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
Thomas R. Webb et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
In Vitro Studies of Non Poly Alanine PHOX2B Mutations Argue Against a Loss-of-Function Mechanism for Congenital Central Hypoventilation
Delphine Trochet et al.
HUMAN MUTATION (2009)
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
Isabelle Janoueix-Lerosey et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cholinergic switch associated with morphological differentiation in neuroblastoma
Franck Bourdeaut et al.
JOURNAL OF PATHOLOGY (2009)
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joelel Vermeulen et al.
LANCET ONCOLOGY (2009)
Copy number variation at 1q21.1 associated with neuroblastoma
Sharon J. Diskin et al.
NATURE (2009)
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso et al.
NATURE GENETICS (2009)
The epidemiology of neuroblastoma: a review
Julia E. Heck et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2009)
Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison
Alexis B. Rothenberg et al.
PEDIATRIC RADIOLOGY (2009)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors
Ultan McDermott et al.
CANCER RESEARCH (2008)
Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes
Anne Fix et al.
GENES CHROMOSOMES & CANCER (2008)
Genotype-phenotype correlations in MYCN-related Feingold syndrome
Carlo L. M. Marcelis et al.
HUMAN MUTATION (2008)
MYCN regulates oncogenic MicroRNAs in neuroblastoma
Johannes H. Schulte et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma:: A report from the children's oncology group
Jennifer Schneiderman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Screening for neuroblastoma: a resurrected idea?
John M. Maris et al.
LANCET (2008)
Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study
Eiso Hiyama et al.
LANCET (2008)
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
Kristina A. Cole et al.
MOLECULAR CANCER RESEARCH (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
John M. Maris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The MYCN oncogene is a direct target of miR-34a
J. S. Wei et al.
ONCOGENE (2008)
A Constitutional Translocation t(1;17)(p36.2;q11.2) in a Neuroblastoma Patient Disrupts the Human NBPF1 and ACCN1 Genes
Karl Vandepoele et al.
PLOS ONE (2008)
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
Erik Fredlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A mouse model for EML4-ALK-positive lung cancer
Manabu Soda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann et al.
GENOME BIOLOGY (2008)
Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma:: The ESCALE study (SFCE)
Caroline Munzer et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin
F. Bourdeaut et al.
ONCOGENE (2008)
Deregulated Wnt/β-catenin program in high-risk neuroblastomas without MYCN amplification
X. Liu et al.
ONCOGENE (2008)
Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications
James G. Bilsland et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Prevalence and functional consequence of PHOX2B mutations in neuroblastoma
E. H. Raabe et al.
ONCOGENE (2008)
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature
N. Tomioka et al.
ONCOGENE (2008)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
Clinical and molecular aspects of RAS related disorders
E. Denayer et al.
JOURNAL OF MEDICAL GENETICS (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
ArrayCGH-based classification of neuroblastoma into genomic subgroups
Evi Michels et al.
GENES CHROMOSOMES & CANCER (2007)
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression
Yael P. Mosse et al.
GENES CHROMOSOMES & CANCER (2007)
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C. Welch et al.
ONCOGENE (2007)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells
Pietro Laneve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
An orally available small-molecule inhibitor of c-met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
Helen Y. Zou et al.
CANCER RESEARCH (2007)
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
Rani E. George et al.
PLOS ONE (2007)
High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays
Jane Carr et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
Anna V. Galkin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome
Ruediger Spitz et al.
GENES CHROMOSOMES & CANCER (2006)
Customized oligonucleotide microarray gene expression based classification of neuroblastoma patients outperforms current clinical risk stratification
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The Myc oncoprotein as a therapeutic target for human cancer
Marina Vita et al.
SEMINARS IN CANCER BIOLOGY (2006)
Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage
Jaouhar Mourali et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number
Qun Wang et al.
CANCER RESEARCH (2006)
PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations
Carmel McConville et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma
RL Stallings et al.
CANCER RESEARCH (2006)
Treatment complications in children diagnosed with neuroblastoma during a screening program
SP Barrette et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Translocation-excision-deletion-amplification mechanism leading to nonsyntenic coamplification of MYC and ATBF1
N Van Roy et al.
GENES CHROMOSOMES & CANCER (2006)
Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction
D Trochet et al.
HUMAN MOLECULAR GENETICS (2005)
Preferential occurrence of chromosome breakpoints within early replicating regions in neuroblastoma
I Janoueix-Lerosey et al.
CELL CYCLE (2005)
Chromosome 1p and 11q deletions and outcome in neuroblastoma
EF Attiyeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
A Schramm et al.
ONCOGENE (2005)
A novel gene family NBPF: Intricate structure generated by gene duplications during primate evolution
K Vandepoele et al.
MOLECULAR BIOLOGY AND EVOLUTION (2005)
Hligh-resolution detection, and mapping of genomic DNA alterations in neuroblastoma
YP Mosse et al.
GENES CHROMOSOMES & CANCER (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Biological role of anaplastic lymphoma kinase in neuroblastoma
Y Osajima-Hakomori et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain
G Schleiermacher et al.
ONCOGENE (2005)
MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome
H van Bokhoven et al.
NATURE GENETICS (2005)
Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma
J Vandesompele et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas
M Ohira et al.
CANCER CELL (2005)
PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome
D Trochet et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Altered expression of cell cycle genes distinguishes aggressive neuroblastoma
AL Krasnoselsky et al.
ONCOGENE (2005)
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma
D Trochet et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Variety and complexity of chromosome 17 translocations in neuroblastoma
G Schleiermacher et al.
GENES CHROMOSOMES & CANCER (2004)
CDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma -: art. no. 70
QR Chen et al.
BMC GENOMICS (2004)
Genetic epidemiology of neuroblastoma: A study of 426 cases at the Institut Gustave-Roussy in France
T Shojaei-Brosseau et al.
PEDIATRIC BLOOD & CANCER (2004)
High-resolution mapping of amplicons of the short arm of chromosome I in two neuroblastoma tumors by microarray-based comparative genomic hybridization
A Fix et al.
GENES CHROMOSOMES & CANCER (2004)
Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas
WT Su et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Germline PHOX2B mutation in hereditary neuroblastoma
YP Mosse et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation
P Adam et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase
SD Turner et al.
ONCOGENE (2003)
ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript:: report of 2 cases
M Onciu et al.
BLOOD (2003)
Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome
J Amiel et al.
NATURE GENETICS (2003)
Rearrangements and increased expression of cyclin DI (CCNDI) in neuroblastoma
JJ Molenaar et al.
GENES CHROMOSOMES & CANCER (2003)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma
G Schleiermacher et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature
D Satge et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma
Y Mosse et al.
LANCET ONCOLOGY (2003)
Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma
B Berwanger et al.
CANCER CELL (2002)
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation
PS Knoepfler et al.
GENES & DEVELOPMENT (2002)
Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types
GE Stoica et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines
I Miyake et al.
ONCOGENE (2002)
Neuroblastoma screening at one year of age
FH Schilling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines
N Van Roy et al.
GENES CHROMOSOMES & CANCER (2001)
Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin
GE Stoica et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of the ALK tyrosine kinase gene in neuroblastoma
L Lamant et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
